Global Medical REIT
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Global Medical REIT generated cash of $68,440,000, which is less than the previous year. Cash used in financing activities reached the amount of -$143,787,000 last year. Net change in cash is therefore -$7,731,000.
Cash Flow
| 2014 | -146.26K | -21.88M | 22.18M |
|---|---|---|---|
| 2015 | -208.80K | -32.33M | 41.64M |
| 2016 | -2.72M | -150.35M | 163.56M |
| 2017 | 11.60M | -252.65M | 226.48M |
| 2018 | 24.83M | -151.61M | 124.51M |
| 2019 | 36.42M | -258.19M | 224.11M |
| 2020 | 34.52M | -223.67M | 192.72M |
| 2021 | 68.96M | -194.66M | 127.70M |
| 2022 | 76.54M | -137.25M | 62.40M |
| 2023 | 68.44M | 67.61M | -143.78M |
GMRE Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 14.45M | 12.75M | 10.75M | 7.18M | 4.84M | 7.11M | 19.67M | 9.18M | 88.80K | 3.51K |
Operating activities | ||||||||||
Net income | 20.61M | 19.99M | 18.34M | -2.49M | 9.58M | 14.56M | -87K | -6.35M | -1.60M | -652.20K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 59.00M | 57.66M | 47.30M | 36.81M | 25.51M | 17.95M | 10.13M | 2.37M | 659.67K | 129.08K |
Stock-based compensation expense | 4.24M | 4.68M | 5.81M | 5.31M | 3.33M | 2.67M | 1.79M | 1.68M | 0 | 0 |
| Deferred income tax benefit | 4.24M | 4.68M | 5.81M | 5.31M | 3.33M | 2.67M | 1.79M | 1.68M | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 426K | -2.97M | -657K | -1.60M | -2.14M | -2.20M | -492K | -212.43K | 2.79K | -8.37K |
Inventories | 0 | 0 | 200K | -1.72M | 584K | 79K | 443K | 710.30K | 0 | 0 |
Accounts payable | -2.02M | 4.06M | 1.92M | 1.56M | 857K | 1.51M | 1.35M | -39.50K | 0 | 0 |
Cash generated by operating activities | 68.44M | 76.54M | 68.96M | 34.52M | 36.42M | 24.83M | 11.60M | -2.72M | -208.80K | -146.26K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -1.97M | -2.77M | -1.53M | -1.68M | -373K | -426K | -797.81K | -385.10K | 0 |
Investments In Property Plant And Equipment | 0 | -156.20M | -201.66M | -218.78M | -256.80M | -180.83M | -252.22M | -150.45M | -32.20M | -21.86M |
Acquisitions Net | 0 | 1.97M | 2.77M | -5.09M | 0 | 0 | 0 | -140.37K | 0 | 0 |
Cash generated by investing activities | 67.61M | -137.25M | -194.66M | -223.67M | -258.19M | -151.61M | -252.65M | -150.35M | -32.33M | -21.88M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 9.89M | 205.52M | 53.08M | 189.49M | 0 | 33.79M | 137.28M | 0 | 0 |
Payments for dividends | -64.84M | -64.24M | -58.32M | -45.76M | -34.99M | -24.78M | -15.97M | -3.87M | -255.6K | -42.62K |
Repurchases of common stock | 0 | 0 | 221.6M | 253.2M | 0 | 0 | 0 | 70.97M | 0 | 0 |
Repayments of term debt | -86.08M | 121.94M | -232.20M | -64.96M | 0 | -115.35M | 136.77M | -37.97M | 42.28M | -306.85K |
Cash used in financing activities | -143.78M | 62.40M | 127.70M | 192.72M | 224.11M | 124.51M | 226.48M | 163.56M | 41.64M | 22.18M |
Net Change In Cash | -7.73M | 1.69M | 2.00M | 3.56M | 2.34M | -2.27M | -14.56M | 10.48M | 9.09M | 159.46K |
Cash at end of period | 6.72M | 14.45M | 12.75M | 10.75M | 7.18M | 4.84M | 5.10M | 19.67M | 9.18M | 162.98K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |